Clearside Biomedical Inc

General ticker "CLSD" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $76.5M

Clearside Biomedical Inc does not follow the US Stock Market performance with the rate: -23.5%.

Estimated limits based on current volatility of 5.2%: low 0.85$, high 0.94$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.74$, 1.66$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.79$, 1.73$]

Financial Metrics affecting the CLSD estimates:

  • Negative: Non-GAAP EPS, $ of -0.53 <= 0.10
  • Negative: Operating profit margin, % of -75.13 <= 1.03
  • Negative: Operating cash flow per share per price, % of -21.79 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating profit margin (median), % of -70.04 <= 2.14
  • Negative: Inventory ratio change, % of 12.48 > 1.08

Similar symbols

Short-term CLSD quotes

Long-term CLSD plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $29.57MM $1.33MM $8.23MM
Operating Expenses $30.20MM $31.60MM $33.07MM
Operating Income $-0.63MM $-30.28MM $-24.84MM
Non-Operating Income $1.00MM $-2.67MM $-7.64MM
Interest Expense $0.00MM $3.34MM $9.36MM
R&D Expense $18.54MM $19.63MM $20.85MM
Income(Loss) $0.38MM $-32.95MM $-32.48MM
Profit(Loss) $0.38MM $-32.95MM $-32.48MM
Stockholders Equity $37.98MM $10.61MM $-15.91MM
Inventory $0.92MM $0.00MM $0.00MM
Assets $42.90MM $51.30MM $34.02MM
Operating Cash Flow $-10.73MM $-13.37MM $-18.14MM
Capital expenditure $0.00MM $0.25MM $1.78MM
Investing Cash Flow $0.00MM $-0.25MM $-1.78MM
Financing Cash Flow $23.78MM $31.33MM $0.41MM
Earnings Per Share* $0.01 $-0.57 $-0.53

* EPS are Split Adjusted, recent splits may be reflected with a delay.